Kidney notes: SMOFlipid
SMOFlipid 20% (Fresenius Kabi Austria GmbH) is a lipid emulsion of soybean oil, medium-chain triglycerides, olive oil and fish oil, used as the energy and essential fatty acid component of parenteral nutrition. Philippine registrations: 100 ml and 250 ml glass bottles.
Composition
| Per presentation | per 1000 ml |
|---|---|
| Soybean oil, refined (g) | 60 |
| Medium-chain triglycerides (g) | 60 |
| Olive oil, refined (g) | 50 |
| Fish oil, rich in omega-3 fatty acids (g) | 30 |
| Energy (kcal) | 2000 |
| Sodium, up to (mmol) | 5 |
- Osmolality approximately 380 mosm/kg; pH approximately 8 (SmPC). Contains no potassium; phosphate from egg phospholipids is not stated in the SmPC.
Composition from the cited manufacturer SmPC/package insert; values independently re-checked November 17, 2026.
Dose and rate limits
- Adults: 1.0 to 2.0 g fat/kg body weight per day (5 to 10 ml/kg/day); infusion rate should not exceed 0.15 g fat/kg/hour (SmPC 4.2).
Kidney notes
- Contraindicated in "severe renal insufficiency without access to hemofiltration or dialysis" (SmPC 4.3).
- Give with caution in impaired lipid metabolism, which may occur in renal failure; clinical data in renal failure are limited (SmPC 4.4).
- Monitor serum triglycerides: they should generally not exceed 3 mmol/l during infusion (SmPC 4.4).
How it fits the ESPEN 2021 kidney nutrition guideline
- ESPEN 2021 Recommendation 27: "There is not enough evidence to support the routine use of omega-3 polyunsaturated fatty acids (PUFA) supplements or PN solutions enriched with omega-3 PUFA in hospitalized patients with AKI, AKI on CKD or CKD with KF." Grade of recommendation GPP – Strong consensus (95.8% agreement).
- ESPEN 2021 Recommendation 14: "For patients undergoing KRT, the total energy provision by additional calories given in the form of citrate, lactate, and glucose from dialysis/hemofiltration solutions should be included in the calculations to determine the total daily energy provision to avoid overfeeding." Grade of recommendation B – Strong consensus (100% agreement). (KRT, kidney replacement therapy.)
- ESPEN 2021 Recommendation 25: "The choice of the most appropriate EN or PN formula should be made based on the calorie and protein ratio to provide the most accurate dosing in clinical practice." Grade of recommendation B – Strong consensus (91.3% agreement). (PN, parenteral nutrition.)
Bottom line
A mixed-oil lipid emulsion; in severe renal insufficiency it needs dialysis or hemofiltration access. Check triglycerides, which can rise in kidney failure. ESPEN does not support routine omega-3-enriched PN in kidney disease, so the fish oil content is not a reason to prefer it for kidney patients.
renalcarematters.com notes, reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. Check the current Philippine package insert before use. renalcarematters.com, reviewed